GB1356965A - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
GB1356965A
GB1356965A GB1659171A GB1659171A GB1356965A GB 1356965 A GB1356965 A GB 1356965A GB 1659171 A GB1659171 A GB 1659171A GB 1659171 A GB1659171 A GB 1659171A GB 1356965 A GB1356965 A GB 1356965A
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
pharmaceutical compositions
composition
tay
anton
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1659171A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ANTON-TAY F
Original Assignee
ANTON-TAY F
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ANTON-TAY F filed Critical ANTON-TAY F
Publication of GB1356965A publication Critical patent/GB1356965A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB1659171A 1970-05-25 1971-05-24 Pharmaceutical composition Expired GB1356965A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4039370A 1970-05-25 1970-05-25

Publications (1)

Publication Number Publication Date
GB1356965A true GB1356965A (en) 1974-06-19

Family

ID=21910742

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1659171A Expired GB1356965A (en) 1970-05-25 1971-05-24 Pharmaceutical composition

Country Status (8)

Country Link
US (1) US3642994A (enExample)
BE (1) BE767566A (enExample)
CA (1) CA960966A (enExample)
DE (1) DE2125427A1 (enExample)
FR (1) FR2100679B1 (enExample)
GB (1) GB1356965A (enExample)
NL (1) NL7106993A (enExample)
ZA (1) ZA713249B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4654361A (en) * 1986-01-27 1987-03-31 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Method of lowering intraocular pressure using melatonin
GB8727099D0 (en) 1987-11-19 1987-12-23 Cellena Cell Eng A G Compositions containing melantonin/homologues
GB2225517B (en) * 1988-11-26 1993-03-31 Motorola Inc Telephone circuits
AU5787999A (en) * 1998-08-26 2000-03-21 Andrei Zakharovich Afanasiev Method for treating neurodegenerative disorders
US7361681B2 (en) * 2003-03-28 2008-04-22 Sygnis Bioscience Gmbh & Co. Kg Method of treating amytrophic lateral sclerosis using melatonin
WO2010062153A1 (es) * 2008-11-27 2010-06-03 GARCÍA PÉREZ, Miguel, Ángel Composiciones farmacéuticas que contienen melatonina para tratar quemadura en tejidos y órganos internos causadas por sustancias corrosivas

Also Published As

Publication number Publication date
FR2100679B1 (enExample) 1975-06-06
US3642994A (en) 1972-02-15
NL7106993A (enExample) 1971-11-29
DE2125427A1 (de) 1971-12-09
BE767566A (fr) 1971-11-24
ZA713249B (en) 1972-01-26
FR2100679A1 (enExample) 1972-03-24
CA960966A (en) 1975-01-14

Similar Documents

Publication Publication Date Title
GB1458349A (en) Composition for and a process therewith of treating the hair and/or scalps of animals
IL36299A0 (en) 3-octadecyloxypropyl-2'-trimethylammoniumethyl phosphate,its preparation and pharmaceutical compositions containing it
GB1388358A (en) Taste-improving formulations of oral penicillins
GB1356965A (en) Pharmaceutical composition
GB1491503A (en) Method of preventing and treating thrombosis
IL36211A0 (en) N(6)-aralkyl-adenosine derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
GB1341794A (en) Medicament for the treatment of hepatic disorders
IL41035A (en) N-lysergyl-3'-amino-pyridine derivatives,their production and pharmaceutical compositions containing them
GB1423985A (en) Pharmaceutical compositions containing bischromonyloxy compounds
GB1270049A (en) New pharmaceutical product
IE34609B1 (en) Antineoplastic therapeutic compositions
ZA75160B (en) Novel compounds and compositions for treating parkinson's disease
CA922691A (en) Process for the preparation of 21-deoxy-21-n-/n' -methylpiperazinyl/ -prednisolone and salts
GB1327466A (en) Pharmaceutical compositions for inhibiting indoleamine-n- methyl transferase
MY7800147A (en) 3'-4' - dideoxykanamycin b active against resistant bacteria, and its synthesis
GB1250279A (enExample)
GB1247073A (en) Novel benzyl-hydrazide derivatives and a process for the manufacture thereof and novel benzylidene-hydrazide derivatives useful in said process
CA953715A (en) N(6)-(2,5-dimethylbenzyl)-2-chloroadenosine derivatives, process for their preparation and pharmaceutical compositions containing the same
ES371392A1 (es) Procedimiento para la produccion de una oxacinobenzodiaze- pina.
ZA715494B (en) Treatment of parkinson's disease
CA945544A (en) 16-METHYLENE-9.beta., 10.alpha.-STEROID COMPOUNDS, PHARMACEUTICAL PREPARATIONS WHICH CONTAIN THE NOVEL COMPOUNDS AS ACTIVE INGREDIENTS, AND METHODS OF PRODUCING THE SAID COMPOUNDSAND PREPARATIONS
GB1242742A (en) Drug for stimulating the central nervous system
GB1264695A (enExample)
GB1127748A (en) Pharmaceutical compositions for use in the treatment of disturbances due to luteinic deficiency
CA964582A (en) Combination of l-dopa and 2-imino-5-phenyl-4-oxazolidinone used to treat parkinson's disease

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]